Yoshio Koyanagi

Overview

Best Publications

• NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

  Mamoru Ito;Hidefumi Hiramatsu;Kimio Kobayashi;Kazutomo Suzue

  2143
  Citations

• Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

  Shinji Harada;Yoshio Koyanagi;Naoki Yamamoto

  1293
  Citations

• Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

  Yoshio Koyanagi;Steven Miles;Ronald T. Mitsuyasu;Jean E. Merrill

  1003
  Citations

• HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain.

  W. A. O'brien;Y. Koyanagi;Ali Namazie;Jia-Qi Zhao

  883
  Citations

• Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

  Hirotaka Ebina;Naoko Misawa;Yuka Kanemura;Yoshio Koyanagi

  763
  Citations

• Cytokines alter production of HIV-1 from primary mononuclear phagocytes

  Yoshio Koyanagi;William A. O'Brien;William A. O'Brien;Jia Qi Zhao;David W. Golde

  684
  Citations

• A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection

  Tsutomu Murakami;Toshihiro Nakajima;Yoshio Koyanagi;Kazunobu Tachibana

  592
  Citations

• Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line

  Naoki Yamamoto;Morihisa Okada;Yoshio Koyanagi;Mari Kannagi

  574
  Citations

• High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients

  Shen Pang;Yoshio Koyanagi;Steven Miles;Clayton Wiley

  541
  Citations

• Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

  J. E. Merrill;Y. Koyanagi;I. S. Y. Chen

  475
  Citations

• SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

  Yoriyuki Konno;Izumi Kimura;Keiya Uriu;Masaya Fukushi

  419
  Citations

• Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4.

  R Kikukawa;Y Koyanagi;S Harada;N Kobayashi

  330
  Citations

• Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro

  Kenji Maeda;Hirotomo Nakata;Yasuhiro Koh;Toshikazu Miyakawa

  321
  Citations

• In vivo infection of human T-cell leukemia virus type I in non-T cells.

  Yoshio Koyanagi;Yasuto Itoyama;Naomi Nakamura;Keita Takamatsu

  306
  Citations

• Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism.

  S. Horiuchi;Y. Koyanagi;Yongwei Zhou;H. Miyamoto

  287
  Citations

• Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1.

  J. E. Merrill;Y. Koyanagi;J. Zack;L. Thomas

  279
  Citations

• Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.

  H Nakashima;M Masuda;T Murakami;Y Koyanagi

  237
  Citations

• Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection.

  Yasuhiko Munakata;Takako Saito-Ito;Keiko Kumura-Ishii;Jie Huang

  231
  Citations

• Host Factor SAMHD1 Restricts DNA Viruses in Non- Dividing Myeloid Cells

  Joseph A. Hollenbaugh;Peter Gee;Jonathon Baker;Michele B. Daly;Michele B. Daly

  227
  Citations

• A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.

  Kozi Ichiyama;Sei Yokoyama-Kumakura;Yuetsu Tanaka;Reiko Tanaka

  226
  Citations